Nuclear Pore Composition Regulates Neural Stem/progenitor Cell Differentiation in the Mouse Embryo
Overview
Reproductive Medicine
Affiliations
Serving as the primary conduit for communication between the nucleus and the cytoplasm, nuclear pore complexes (NPCs) impact nearly every cellular process. The extent to which NPC composition varies and the functional significance of such variation in mammalian development has not been investigated. Here we report that a null allele of mouse nucleoporin Nup133, a structural subunit of the NPC, disrupts neural differentiation. We find that expression of Nup133 is cell type and developmental stage restricted, with prominent expression in dividing progenitors. Nup133-deficient epiblast and ES cells abnormally maintain features of pluripotency and differentiate inefficiently along the neural lineage. Neural progenitors achieve correct spatial patterning in mutant embryos; however, they are impaired in generating terminally differentiated neurons, as are Nup133 null ES cells. Our results reveal a role for structural nucleoporins in coordinating cell differentiation events in the developing embryo.
Nuclear envelope and chromatin choreography direct cellular differentiation.
Nair A, Khanna J, Kler J, Ragesh R, Sengupta K Nucleus. 2025; 16(1):2449520.
PMID: 39943681 PMC: 11834525. DOI: 10.1080/19491034.2024.2449520.
Chen S, Jiang Q, Fan J, Cheng H Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):84-100.
PMID: 39243141 PMC: 11802349. DOI: 10.3724/abbs.2024145.
Colussi C, Bertozzi A, Leone L, Rinaudo M, Sollazzo R, Conte F Stem Cell Res Ther. 2024; 15(1):275.
PMID: 39227892 PMC: 11373261. DOI: 10.1186/s13287-024-03805-1.
TorsinA is essential for neuronal nuclear pore complex localization and maturation.
Kim S, Phan S, Tran H, Shaw T, Shahmoradian S, Ellisman M Nat Cell Biol. 2024; 26(9):1482-1495.
PMID: 39117796 PMC: 11542706. DOI: 10.1038/s41556-024-01480-1.
Advances in the understanding of nuclear pore complexes in human diseases.
Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X J Cancer Res Clin Oncol. 2024; 150(7):374.
PMID: 39080077 PMC: 11289042. DOI: 10.1007/s00432-024-05881-5.